It's time to put an end to one-size-fits-all drug dosing

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.

Teresa Cope, CEO of Manx Care, outlines the Isle of Man government's 2026 Innovation Challenge, an initiative designed to attract technology solutions that can support the Island's vision for digitally enabled, sustainable healthcare.